Regular exercise may delay decline in those at risk of Alzheimer’s
By
Alicia Lasek
Aug 09, 2019
Moderate exercise appears to help preserve memory and curb brain changes in people at risk of Alzheimer’s, new studies show.
Clinical briefs for Wednesday, April 14
By
Alicia Lasek
Apr 14, 2021
NIH updates monoclonal antibody COVID treatment protocols … Surveyed community pharmacists say vaccine supply is bigger problem than patient reluctance … B.1.1.7 variant more transmissible but does...
Quitting smoking reverses lung cell damage: study
By
Alicia Lasek
Jan 30, 2020
Quitting appears to reawaken healthy cells, triggering airways to regrow a new lining – even in lifelong smokers.
Clinical briefs for Friday, Sept. 1
By
Kristen Fischer
Sep 01, 2023
Gene seems to protect some from Alzheimer’s, Parkinson’s … Sweating, seizure activity common day before heart attack … SSRIs can up arrhythmia risk in some people … Probiotics improve...
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
Clinical briefs for Tuesday, July 20
By
Liza Berger
Jul 20, 2021
COVID-19 breakthrough cases more often affect seniors, survey of health officials finds … COVID-19 antibodies still around nine months after infection … High blood pressure variability is associated...
Clinical briefs for Wed., Sept. 13
By
Kristen Fischer
Sep 13, 2023
Racial disparities emerge in people with frontotemporal dementia … Docs find success with new treatments for persistent C. difficile … Inverse vaccine looks good so far to reverse MS, type 1 diabetes...
Clinical briefs for Tuesday, April 6
By
Alicia Lasek
Apr 06, 2021
COVID outbreak among vaccinated assisted living residents under investigation … FDA rejects bid to approve Nuplazid for treatment of dementia-related psychosis … J&J betting $780M on long-acting antiviral...
Adopt new test, and take race out of kidney disease diagnostics, clinicians urged
By
Alicia Lasek
Sep 24, 2021
Fewer Black patients will be left unaware of their true kidney function status if their healthcare providers switch to a diagnostic test that doesn’t rely on a race variable, according to a new report...
New drug may guard against Alzheimer’s-related memory loss
By
Alicia Lasek
Sep 10, 2019
A new trial drug may help to protect memory – even when a person’s brain has developed signs of Alzheimer’s disease, according to ongoing research.